Squamoid Eccrine Ductal Carcinoma of the Eyelid: Clinicopathologic Correlation of a Case
Recommended Citation
Patel N, Alabiad CR, Wick MR, Elgart GW, Tang VD, Abou Khzam RA, and Dubovy SR. Squamoid Eccrine Ductal Carcinoma of the Eyelid: Clinicopathologic Correlation of a Case. Ophthalmic Plast Reconstr Surg 2022; 38(3):e80-e82.
Document Type
Article
Publication Date
5-1-2022
Publication Title
Ophthalmic Plast Reconstr Surg
Abstract
Squamoid eccrine ductal carcinoma (SEDC) is a rare cutaneous neoplasm that often manifests as a plaque or nodule in sun-exposed areas of older patients. Herein, the authors report the first case of SEDC in the eyelid. A 76-year-old man presented with a 2.5 × 1.5 mm area of left upper eyelid erythema, thickening, ulceration, and scaling with madarosis superotemporally just above the lash line. Full-thickness wedge biopsy demonstrated irregular epithelial tubules with nuclear atypia and focal squamous differentiation, consistent with SEDC. The patient underwent Mohs resection and has had no recurrence approximately 27 months after surgical removal. The authors present this case to raise awareness of SEDC to ophthalmologists as all previous cases have been described in the nonophthalmic literature. A full-thickness biopsy is recommended to avoid misdiagnosing SEDC as squamous cell carcinoma (SCC), a less aggressive tumor. With greater awareness, there may be increased recognition of this likely underreported, more malignant entity.
Medical Subject Headings
Adenocarcinoma, Clear Cell; Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Squamous Cell; Eccrine Glands; Eyelid Neoplasms; Eyelids; Humans; Male; Sweat Gland Neoplasms
PubMed ID
35561118
Volume
38
Issue
3
First Page
80
Last Page
80